Aclarion, Inc. (ACON): Nasdaq/NYSE listing notice — Aclarion receives Nasdaq equity deficiency notice; stockholders' equity $1.79M vs $2.5M minimum

Aclarion, Inc.

Stockholders' equity reported at $1,787,751 as of Dec 31, 2023 falls below $2.5M Nasdaq minimum.
Company must submit compliance plan by April 17, 2023; extension possible to Aug 30, 2023.
Separately, Nasdaq bid price deficiency notice received Dec 20, 2022; cure period through June 20, 2023.
No immediate impact on listing; company evaluating options including a potential reverse stock split.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Aclarion, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

March 3, 2023, Aclarion, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December 31, 2023, the Company reported stockholders’ equity of $1,787,751, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the Company’s

View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Aclarion, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-23-001360

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.